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Mental adjustment to cancer and survival of patients
admitted for allogenic hemopoietic stem cell
transplantation: a prospective cohort study
KrankheitsverarbeitungundÜberlebenszeitvonPatientenunterallogener
hämatopoietischer Stammzelltransplantation: eine prospektive
Kohortenstudie
Abstract
Objective: The Mental Adjustment to Cancer Scale (MAC scale) has
evolved to a standard measure in the field of psycho-oncology. In this
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context an attitude called "fighting spirit" gained much attention as a
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coping style. Some reports suggest that coping efforts as measured by
Horst Kächele
1 the MAC scale are predictive for survival of breast cancer patients. We
explored the predictive power of the MAC scale by using a sample of
patients with haematological malignancies undergoing allogenic
hemopoietic stem cell transplantation (HSCT). 1 Universitätsklinik für
Psychosomatische Medizin Methods: Between 9/1999 and 12/2001 127 patients were admin-
istered the MAC scale prior to HSCT. Follow-up data of overall survival
und Psychotherapie, Ulm,
Germany
andevent-freesurvivalwereobtainedinDecember2003andanalyzed
using Cox-regression models. 2 Institut für Medizinische
Psychologie der Universität
Tübingen,Tübingen,Germany Results: At the time of the follow-up, 68 patients had died (overall sur-
vival), 75 patients had experienced a relapse or had died (event-free
survival).WefailedtofindsignificantresultsfortheMACsubscaleswith
and without adjustment for prognostic factors.
Conclusion: In the special situation of patients facing HSCT the MAC
scale seems not to be of predictive value. In general, with respect to
survival the empirical evidence is not very convincing.
Keywords: survival, psychological response, coping, neoplasm, stem
cell transplantation
Zusammenfassung
Zielsetzung: Die Mental Adjustment to Cancer Scale (MAC-Skala) hat
sich im Feld der Psychoonkologie zu einem Standardmessinstrument
entwickelt. In diesem Zusammenhang gewann ein als "fighting spirit"
bezeichneter Bewältigungsstil breite Aufmerksamkeit. In manchen
Studien wurde berichtet, dass mit der MAC-Skala erfasste Krankheits-
verarbeitungsweisen mit späterer Überlebensdauer korreliert sind. Wir
untersuchten die Vorhersagekraft der MAC-Skala in einer Stichprobe
von Patienten mit hämatologischen Erkrankungen, die sich einer allo-
genenhämatopoietischenStammzelltransplantation(HSZT)unterzogen.
Methode:Zwischen9/1999und12/2001bearbeiteten127Patienten
die MAC-Skala vor Durchführung der HSZT. Ein Follow-up im Hinblick
aufÜberlebenszeiterfolgteimDezember2003.DieÜberlebenszeitdaten
wurden mit Cox-Regressionsmodellen evaluiert.
Ergebnisse: 68 Patienten waren verstorben, 75 Patienten waren ver-
storben oder erlitten Rezidiv. Es wurden mit und ohne Adjustierung
bezüglich medizinischer Prognosefaktoren keine signifikanten Zusam-
menhänge einer der MAC-Subskalen mit der allgemeinen und der
krankheitsfreien Überlebenszeit gefunden.
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VorhersagewertfürdieÜberlebenszeitzuhaben.Jedochgiltauchallge-
mein,dassdieempirischeEvidenzindieserHinsichtnichtüberzeugend
ist.
Introduction
The introduction's first part addresses the background
of the development of the Mental Adjustment to Cancer
Scale (MAC scale) that internationally gained wide atten-
tion. We assume that this development would not have
taken place if the intriguing idea of a fighting spirit pro-
longing survival time for cancer patients had not been
raised.In the secondpart we outlineour interestand the
background of our study.
In 1972, Greer and colleagues started studying a total of
62 women diagnosed with early breast cancer. Based on
clinical interviews they discovered that those patients
who had a fighting attitude or were in denial had an ad-
vantagewithrespecttosurvivaltime.Thisadvantagewas
confirmed in 5, 10, and 15 year follow-ups [1], [2]. Sub-
sequently, this research group developed the Mental
Adjustment to Cancer Scale (MAC scale) as a question-
naire, which correlated reliably well with the clinical rat-
ings [3]. This questionnaire assesses how the patients
cope with the cancerexperience.It evaluates five dimen-
sions: fighting spirit (FS), helplessness/hopelessness
(HH), anxious preoccupation (AP), fatalism (F), and
avoidance (A).This instrument found wide international
attentionandis in usein severallanguages,e.g. Chinese
[4], French [5]; German [6], Greek [7]; Italian [8]; Japan-
ese[9];Swedish[10]).Inthefieldofpsycho-oncologythe
MAC scale seems to have advanced towards a standard
measure. It is in use not only to assess coping styles but
servestoevaluatetheoutcomeofpsychosocialinterven-
tions [11], [12] as well.
The idea of a fighting spirit has spread and was broadly
discussed in the relevant literature, both inside and out-
side academia.Especiallyin the non-academicworld the
findings of Greer and his group fostered the idea that
being positive enough all the time and keeping up your
fightingattitude,youcanbeatcancerwithyourmind.But
this idea raised fear for several patients that they under-
mine their perspectives if they do not sustain positive
thinking and maintain their fighting spirit irrespective of
their actual situation. What was assumed as beneficial
could become a source of distress following feelings of
guilt or failure.
In 1999, Watson and colleagues [13] published the re-
sultsofaprospectivestudythatwasintendedtoreplicate
the earlier findings of Greer and colleagues [1], [2]. In
this impressing study with sound methodology, 578 wo-
men with early-stage breast cancer were followed up for
at least five years. Women were aware of their diagnosis
and were enrolled 4-12 weeks after diagnosis. The out-
come measures were overall survival and event-free
survival controlled for known prognostic factors. They
couldnotconfirmthehypothesisofaconnectionbetween
fighting spirit and survival but identified a statistical sig-
nificantrelationbetweenthedichotomizedMACsubscale
helplessness/hopelessness(HH)andevent-freesurvival
(adjusted hazard ratio (HR) 1.55, 95%-CI = 1.07-2.25).
TheassociationbetweenoverallsurvivalandHHreached
only a weak tendency (adjusted HR 1.30, 95%-CI = 0.84-
2.00). Most recently Watson et al. [14] report on their
findings of the 10-year follow-up with results for HH and
survival (event-free survival: adjusted HR 1.53, 95%-CI =
1.11-2.11, overall survival: adjusted HR 1.34, 95%-CI =
0.95-1.89) comparable to their initial findings [13]. With
respect to the above mentioned pressure to maintain a
fighting attitude Watson et al. [13] concluded that their
"findings suggest that women can be relieved of the bur-
den of guilt that occurs when they find it difficult to
maintain a fighting spirit" (p. 1335).
Since more than twenty years, our research group has a
special interest in the field of coping with bone marrow
transplantation/hemopoietic stem cell transplantation
(HSCT)[15],[16],[17],[18],[19].Theideathatafighting
attitude would be beneficial to adjust to cancer and sur-
vival was still a common hypothesis, even though a con-
vincingempiricalbasiswasstilllacking.In a firstexplora-
torystudyfocusingonpatientswithleukaemiaundergoing
allogenicbonemarrowtransplantationthatwererecruited
in the period form 1990 to 1995 our group found empir-
icalsupportforapossiblelinkbetweencopingstrategies
(labelled "fighting spirit") and survival using the Ulm
Coping Manual (UCM) [19], [20], [21]. Raters had to
evaluateaudio-tapedinterviewsbasedonthedefinitions
of coping strategies given in the UCM. This procedure is
quite time consuming opposed to a self assessment
questionnaire as the MAC scale.
When we started to design the present investigation in
1997 the results of the Watson et al. study [13] were not
published, but we were determined to explore the MAC
scale in our study group.
The possible link between psychological factors and the
survival rate was and still is a subject of intensive contro-
versies [22], [23], [24], [25], [26] in general as well as
in the field of hemopoietic stem cell transplantation
(HSCT) [19], [27]. Beside the studies by Watson and col-
leagues [13], [14] no other prospective study using the
MACscaleasmeasurehasshownconvincingassociations
to survival time. Three descriptive studies are relevant
for this topic in the field of HSCT [28], [29], [30]. An-
drykowski et al. [28] found that higher levels of MAC
subscale AP were associated with shorter survival time
in a sample of 42 BMT-patients and a median follow-up
periodofapproximatelytwoyears,butfoundnosignificant
results for the other MAC subscales. Jenkins et al. [30]
studied 29 patients pre BMT, and compared deceased
patients and those still living after one and six months
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42 patientsundergoingBMT with FS as the predominant
coping style to the other 26 patients reporting other pre-
dominant coping styles. In both studies, they could not
find an association between MAC scale and the survival
rate. Methodological shortcomings [27], the small num-
bers of participants of these studies, and the heterogen-
eity of results did not offer an empirical basis for a hypo-
thesis testing approach for our study. Therefore, the aim
of our study is to explore whether there exist any links
between coping styles as measured by the MAC scale
administered before performing allogenic HSCT and sur-
vival thereafter.
Patients and methods
The study was approved by the ethics committee of Ulm
University. Inclusion criteria were being eighteen years
of age or older, fluency in German and having been
scheduled for the first allogenic peripheral blood stem
cell or bone marrow transplantation. At hospitalization,
patientswereinformedaboutthestudy,thatparticipation
inthestudywasvoluntaryandthatnonparticipationwould
have noimpactontheirtreatmentin theunit.Priorto the
investigation, written informed consent was obtained
fromthepatientsandquestionnaireswereadministered.
TheywereansweredbeforeHSCT.Afollow-upoftwoyears
was planned for each patient.
Patients
From September 1999 until December 2001, 230 pa-
tients were admitted for allogenic HSCT at the BMT units
oftheUniversityHospitalsofUlmandTübingen,Germany.
Ofthem,31didnotfulfilltheinclusioncriteria,eightwere
not approached in time, and one patient did not proceed
to HSCT. Of the remaining 190 patients, 140 (73.7%)
agreed to participate in our psycho-social study. Our
analysis is restricted to data of 127 patients with a com-
plete data set of target variables (eight questionnaires
with missing values, five patients without the necessary
physicians' assessments). Of these patients, 59% were
male,and80% livedwith a partner. The averageagewas
41 years (range 18-61 years, SD = 11.2). Most of them
had been diagnosed with acute (50%) or chronic (22%)
leukaemia. 34% of the patients received their stem cells
from bone marrow, others from peripheral blood. 91%
receivedHLA-identicaltransplants.Aftertransplantation,
nearly 3 out of 10 patients relapsed, and 53% of all pa-
tients died during the follow up period.
Methods
To measure the psychological response we used the
MentalAdjustmenttoCancerScale[31].Thisinstrument
is a 40-item questionnaire addressing reactions of pa-
tients on having cancer. Items are given as statements,
and patients assess their agreement using a 4-point
Likert-scale(1=definitelydoesnotapplytome,2=does
not apply to me, 3 = applies to me, 4 = definitely applies
to me). Each item is assigned to exactly one of the five
subscales. Scores for the subscales are calculated by
adding up the answers of the assigned items. Following
are examples for items:
• fightingspirit(FS):"IfirmlybelievethatIwillgetbetter";
• helplessness/hopelessness (HH): "I feel that life is
hopeless";
• anxious preoccupation (AP): "I suffer great anxiety
about it";
• fatalism (F) "I've left it all to my doctors";
• avoidance (A; single item scale): "I don't really believe
I had cancer".
Prognostic factors
Thereiscurrentlynosystemavailabletohelpcharacterize
theprognosisforhaematologicaldiseasesingeneral.For
CML, for example, such an index was proposed [32], but
this index is not transferable to acute leukaemia without
making some changes to it. Other recently suggested
prognosticindices,e.g.forlymphomas[33]orcomorbidity
[34], weren't available when we started recruiting, so we
did not determine these indices in our study.
With respect to the diversity of potential risk factors, we
looked for a global indicator for prognosis and decided
to use the transplanting physician's expertise. From an
earlier study performed in Ulm, we knew that physicians'
assessments ascertained before transplantation were
highlypredictiveforlongtermoutcome[35].Afteradmis-
sion to hospital, we asked the physician for an assess-
ment of the patient's prognosis using a 6-point scale (1
= very good, 6 = very poor). To replicate the earlier find-
ings, we checked the prognostic validity of this assess-
ment by using Cox regression and Kaplan-Meier survival
analysis methods. Again, as in the former study, the
physician's assessment was highly predictive of survival
(p<.001): relative risk = 1.48 (95%-CI = 1.22-1.80), i.e.
an increase of 1 point on the scale is associated with an
approximately 50% increased risk to die.
Statistical analyses
TwostrategiestoevaluatetheMACscaleweresuggested
byWatsonetal.[13].First,welookedforthepredominant
response from the subscales FS, HH, F, and AP via calcu-
latingz-scoresforeachscaleandlookedforthesubscale
with the highest z-score. This subscale is the patient's
predominant response. If all z-scores are negative, the
patient is classified as having no predominant response.
The second evaluation used the calculation of cut-off
scoresforallfivesubscales.Thesubscalesaredichotom-
ized at the mean plus one standard deviation to differen-
tiate cases from non-cases. This criterion results in
skewed distributions but has to been seen as "the
standard" in this context.
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the procedures of Watson et al. [13] survival times were
evaluated for all questionnaire subscales subjecting the
corresponding groups (predominant responses; cases
vs. non-cases for all five MAC subscales) as categorical
covariates to Cox-regression analyses with and without
adjustment for physician's prognosis as continuous cov-
ariate. However, with respect to the skewed distributions
of the dichotomized MAC subscales we will explore the
results using the MAC subscale scores as continuous
covariates, too.
Two outcomes were examined by Watson et al. [13]:
overall survival and event-free survival. Overall survival
defines events as cases of death irrespective of the spe-
cific cause of the death. Event-free survival means
survival without relapse and focuses on the time from
the specific starting point to the point when a relapse
wasdiagnosedor,ifnorelapseoccurred,thepatienthad
died.
In our study survival time was calculated as time from
date of HSCT until date of event. If no event was re-
gistered, the case was considered as censored and sur-
vivaltimewascalculatedastimefromHSCTuntilcensor-
ing. For censored cases, the date of the most recent
documentedvisitinthehospitalwasusedforcalculation.
Analyses were performed by using the software package
SPSS for Windows (Release 11.0.1., 15 Nov 2001;
Chicago, Ill.: SPSS Inc.).
Results
We checked the available records in December 2003.
Sixty-eight patients had died. Overall survival therefore
refersto68events.Medianfollow-uptimewas2.54years
(inter-quartile range 2.1-3.2) for censored cases, and
0.53 years (0.26-1.09) for cases. Of the 38 patients with
a relapse post HSCT, 31 died. The seven patients who
hadrelapsedandwerealiveatfollowuprepresentevents
when looking at relapse-free (event-free) survival, thus
resultingin75events.Fortheoutcome event-freesurvival
median follow-up time was 2.51 years (inter-quartile
range:2.0-3.2)forcensoredcases,and0.45years(0.18-
0.97) for cases.
Tables 1 and 2 summarize the results for the Cox regres-
sionanalyses(withandwithoutadjustmentforprognosis)
for the predominant response and the five dichotomized
MAC subscales and for both focused outcomes: overall
survival and event-free survival, respectively. No signific-
ant results are found. All reported 95%-confidence inter-
vals include the hazard ratio 1.0 expressing the same
risk for both groups. There may be a slight trend for the
MAC subscale avoidance (A) showing a decreased risk if
the patient fully agrees to the item "I don't really believe
I had cancer", a trend that is more pronounced in the
case of overall survival.
Our explorative analyses with MAC subscale scores as
continuous covariates do not result in remarkable differ-
encescomparedtotheresultsalreadyreported;therefore
we abstain from reporting these numbers. The trends for
the MAC scale A that were mentioned above clearly
weaken.
4/9 GMS Psycho-Social-Medicine 2006, Vol. 3, ISSN 1860-5214
Grulke et al.: Mental adjustment to cancer and survival of patients ...Table1:Numberofevents(deaths),totals,deathrateandresultsforCoxregressionanalysesforMACscalesand overallsurvival
(hazard ratios with 95%-CI) for n=127 patients (68 events)
5/9 GMS Psycho-Social-Medicine 2006, Vol. 3, ISSN 1860-5214
Grulke et al.: Mental adjustment to cancer and survival of patients ...Table 2: Number of events (relapse or death), totals, event rate, and results for Cox regression analyses for MAC scale and
event-free survival (hazard ratios with 95%-CI) for n=127 patients (75 events)
Discussion
Weassessedthepatients'psychologicalresponsetotheir
disease and treatment by using the established MAC
scale for a sample of 127 patients facing HSCT, and
evaluated overall and event-free survival post HSCT as
outcomes. A physician's assessment of the prognosis,
which proved to be highly predictive for survival, served
as a variable to statistically control somatic risk factors.
Withrespecttofrequencydistributionsandcut-offscores
on the MAC subscales, our results are quite similar to
those reported by Watson and colleagues [13], [14]. We
did not find any relationships between predominant psy-
chological response or any single MAC subscale and
event-freeoroverallsurvival.WithrespecttoHHwecould
not confirm the findings of Watson et al. [13], [14]. The
range of the confidence intervals (HR) for HH is nearby
between halving and doubling the risk. There is no obvi-
ous trend towards a better survival by less HH in our
sample.
It seems that the findings of Watson et al. [13], [14] for
the MAC subscale HH cannot be transferred to the field
of HSCT. This result may have been caused by the differ-
ent interview settings. Women with early-stage breast
cancer who were diagnosed one to three months before
inclusion into the study had quite a good prognosis
compared to patients facing allogenic HSCT. This fact is
clearly reflected by the survival rates in both studies. In
the Watson et al. [13], [14] study, 23% and 38.2% of the
women had died during the five and 10 years of follow-
up respectively, compared to 53% in our study with a
considerableshorterfollow-upperiod.WhenfacingHSCT,
the patients already had passed a significant period of
challenges to cope with. Most of them had suffered from
other stressful therapies (in most cases chemotherapy),
and now they had given informed consent to a life-
threatening treatment. One could speculate that those
patientswhoexhibitpronouncedhelplessness/hopeless-
ness during the first time after diagnosis are less likely
to proceed to the point when HSCT becomes a concrete
option. Provided that we administer the MAC scale quite
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subscale HH could be of predictive power. Unfortunately
wedon'thavesuchabaselinemeasure.Ataskforfurther
research could be to explore the pathways leading to
HSCT and the internal and external factors influencing
the decisions on this way.
The MAC subscale avoidance (A) reflects denial that was
identified as beneficial by Greer et al. [1], [2]. Could it be
a sign of adaptive coping when facing the challenge of
HSCT patients say "I don't really believe I had cancer"? Is
it the ability to deny one's diagnosis in such a situation
that serves as a resource leaving mental capacities to
deal with the demands of the imminent challenges? But
we should not overstress the statistics. At last we only
found a slight trend that probably is a finding by chance.
For the BMT setting, it seems to be unlikely that the MAC
scale can predict survival after transplantation. Maybe
an alternative version of the MAC scale could be more
successful as shown by Osborne et al. [36] for breast
cancer patients. They used a rescaled Australian version
that is comprised of six scales. Two scales referred to
fighting spirit, namely "fighting spirit - minimizing the ill-
ness" and "fighting spirit - positive orientation to the ill-
ness". In their explorative study on 61 women with early
breast cancer, they found a significant association
betweensurvivalandthesubscale"fightingspirit-minim-
izing the illness", but not for the subscale "helpless-
ness/hopelessness"whichisidenticaltotheoriginalHH.
Prior to considering consequences from the findings of
Osborne et al. [36], their results have to be replicated in
ahypothesistestingstudy.Butforbreastcancerpatients
the results with the MAC scale are heterogeneous. Re-
cently, Goodwin et al. [37] did not find any significant
associations between the MAC subscales and survival in
n=225 patients. Based on clinical ratings Greer and col-
leagues [1], [2] discovered "fighting spirit" and "denial"
as predictive. In their attempt to replicate these findings
using the MAC scale Watson et al. [13] identified HH but
neither FS nor avoidance (denial). Their finding of HH
being a predictor, that holds in their 10-years follow-up
[14],mustbeseenasanempiricallygroundedhypothesis.
Maybe all other studies were underpowered, but to avoid
misleading interpretations of a possible chance finding
byWatsonetal.[13],[14]ahypothesis-testingreplication
is necessary.
We focused on survival times but should bear in mind
that originally, the MAC scale was not intended as a
measure to predict survival. Identifying such relations
would contribute towards answering the question "What
is good coping?" But "good coping" should not to be re-
stricted solely to survival. This outcome is one of several
others as for example quality of life, suffering from treat-
ment-relatedsideeffects,orresumingone'sprofessional
activities.
Insummary,withrespecttosurvival,atdatetheempirical
evidence for a predictive value of the MAC scale is not
veryconvincing.FurtherinvestigationswiththeMACscale
should have a clear hypothesis testing approach.
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Erratum
The methodssectionof this articleoutlinesa description
of the Mental Adjustment to Cancer Scale that follows
the original English version. Now, it was brought to our
attention that the wording of the German version that we
used to anchor the response categories does not com-
pletely parallel the original. Therefore this addendum is
needed.
The original English version gives these anchors: 1 =
definitelydoesnotapplytome,2=doesnotapplytome,
3 = applies to me, 4 = definitely applies to me.
The German version in the translation by Hubertz et al.
that we used gives these anchors: 1 = trifft gar nicht zu,
2 = trifft etwas zu, 3 = trifft überwiegend zu, 4 = trifft
vollständig zu.
If we assume equal distances the verbal anchors of the
English version might be translated to the numbers -1.5
/ -0.5 / +0.5 / 1.5 and our German version to 0 / +1 /
+2 / +3. The difference between both scales seems to
be a shift to the positive side in the German version.
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